➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Dow
Mallinckrodt
AstraZeneca
Harvard Business School

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for RO7034067

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for RO7034067?

RO7034067 is an investigational drug.

There have been 5 clinical trials for RO7034067. The most recent clinical trial was a Phase 1 trial, which was initiated on February 1st 2017.

The most common disease conditions in clinical trials are Muscular Atrophy, Spinal, Muscular Atrophy, and Atrophy. The leading clinical trial sponsors are Hoffmann-La Roche and [disabled in preview].

There is one US patent protecting this investigational drug and twenty-seven international patents.

Recent Clinical Trials for RO7034067
TitleSponsorPhase
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7034067 in Healthy Japanese ParticipantsHoffmann-La RochePhase 1
A Study of RO7034067 in Adult and Pediatric Participants With Spinal Muscular AtrophyHoffmann-La RochePhase 2
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of RO7034067 in Type 2 and 3 Spinal Muscular Atrophy Participants (Sunfish)Hoffmann-La RochePhase 2

See all RO7034067 clinical trials

Clinical Trial Summary for RO7034067

Top disease conditions for RO7034067
Top clinical trial sponsors for RO7034067

See all RO7034067 clinical trials

International Patents for RO7034067

Drugname Country Document Number Estimated Expiration Related US Patent
RO7034067 Argentina 100442 2034-05-15   Start Trial
RO7034067 Australia 2015261046 2034-05-15   Start Trial
RO7034067 Canada 2948561 2034-05-15   Start Trial
RO7034067 Chile 2016002836 2034-05-15   Start Trial
RO7034067 China 106459092 2034-05-15   Start Trial
RO7034067 Costa Rica 20160518 2034-05-15   Start Trial
RO7034067 Denmark 3143025 2034-05-15   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Dow
Mallinckrodt
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.